The 2022 OncoAlert Colloquium Day 1: Breast Cancer

Genetic profiling identifies patients who can omit radiation therapy after breast-conserving surgery

HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC

Monitoring and evaluation as a tool for quality improvement in cancer screening

Initiatives in monitoring of cancer screening in low- and middle-income countries

Cancer control in Latin America

Assessment of cervical and breast cancer screening in Latin America and Caribbean: CanScreen5/CELAC project

Long-term breast cancer risk after benign breast disease in population-based screening

Individualised breast cancer risk assessment model for BreastScreen Norway

Molecular profiling in prostate cancer: key challenges for clinical implementation

Genomic testing: Australian model for unlocking the potential of precision oncology for patients and health systems

Intraoperative Radiotherapy